Mireia Recasens1, Beatriz Almolda2, Jeús Pérez-Clausell3, Iain L Campbell4, Berta González1, Bernardo Castellano1. 1. Department of Cell Biology, Physiology and Immunology, Institute of Neuroscience, Universitat Autònoma de Barcelona, 08193, Bellaterra, Barcelona, Spain. 2. Department of Cell Biology, Physiology and Immunology, Institute of Neuroscience, Universitat Autònoma de Barcelona, 08193, Bellaterra, Barcelona, Spain. beatriz.almolda@uab.cat. 3. Department of Cell Biology, Physiology and Immunology, Universitat de Barcelona, 08028, Barcelona, Spain. 4. School of Life and Environmental Sciences and Charles Perkins Centre, University of Sydney, Sydney, NSW, 2006, Australia.
Abstract
BACKGROUND: When the homeostasis of the central nervous system (CNS) is altered, microglial cells become activated displaying a wide range of phenotypes that depend on the specific site, the nature of the activator, and particularly the microenvironment generated by the lesion. Cytokines are important signals involved in the modulation of the molecular microenvironment and hence play a pivotal role in orchestrating microglial activation. Among them, interleukin-6 (IL-6) is a pleiotropic cytokine described in a wide range of pathological conditions as a potent inducer and modulator of microglial activation, but with contradictory results regarding its detrimental or beneficial functions. The objective of the present study was to evaluate the effects of chronic IL-6 production on the immune response associated with CNS-axonal anterograde degeneration. METHODS: The perforant pathway transection (PPT) paradigm was used in transgenic mice with astrocyte-targeted IL6-production (GFAP-IL6Tg). At 2, 3, 7, 14, and 21 days post-lesion, the hippocampal areas were processed for immunohistochemistry, flow cytometry, and protein microarray. RESULTS: An increase in the microglia/macrophage density was observed in GFAP-IL6Tg animals in non-lesion conditions and at later time-points after PPT, associated with higher microglial proliferation and a major monocyte/macrophage cell infiltration. Besides, in homeostasis, GFAP-IL6Tg showed an environment usually linked with an innate immune response, with more perivascular CD11b+/CD45high/MHCII+/CD86+ macrophages, higher T cell infiltration, and higher IL-10, IL-13, IL-17, and IL-6 production. After PPT, WT animals show a change in microglia phenotype expressing MHCII and co-stimulatory molecules, whereas transgenic mice lack this shift. This lack of response in the GFAP-IL6Tg was associated with lower axonal sprouting. CONCLUSIONS: Chronic exposure to IL-6 induces a desensitized phenotype of the microglia.
BACKGROUND: When the homeostasis of the central nervous system (CNS) is altered, microglial cells become activated displaying a wide range of phenotypes that depend on the specific site, the nature of the activator, and particularly the microenvironment generated by the lesion. Cytokines are important signals involved in the modulation of the molecular microenvironment and hence play a pivotal role in orchestrating microglial activation. Among them, interleukin-6 (IL-6) is a pleiotropic cytokine described in a wide range of pathological conditions as a potent inducer and modulator of microglial activation, but with contradictory results regarding its detrimental or beneficial functions. The objective of the present study was to evaluate the effects of chronic IL-6 production on the immune response associated with CNS-axonal anterograde degeneration. METHODS: The perforant pathway transection (PPT) paradigm was used in transgenic mice with astrocyte-targeted IL6-production (GFAP-IL6Tg). At 2, 3, 7, 14, and 21 days post-lesion, the hippocampal areas were processed for immunohistochemistry, flow cytometry, and protein microarray. RESULTS: An increase in the microglia/macrophage density was observed in GFAP-IL6Tg animals in non-lesion conditions and at later time-points after PPT, associated with higher microglial proliferation and a major monocyte/macrophage cell infiltration. Besides, in homeostasis, GFAP-IL6Tg showed an environment usually linked with an innate immune response, with more perivascular CD11b+/CD45high/MHCII+/CD86+ macrophages, higher T cell infiltration, and higher IL-10, IL-13, IL-17, and IL-6 production. After PPT, WT animals show a change in microglia phenotype expressing MHCII and co-stimulatory molecules, whereas transgenic mice lack this shift. This lack of response in the GFAP-IL6Tg was associated with lower axonal sprouting. CONCLUSIONS: Chronic exposure to IL-6 induces a desensitized phenotype of the microglia.
Entities:
Keywords:
Axonal sprouting; MHCII; Monocyte; Primed microglia; T cell
Authors: Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo Journal: Nature Date: 2006-04-30 Impact factor: 49.962
Authors: Ingo Bechmann; Jana Goldmann; Adam D Kovac; Erik Kwidzinski; Eva Simbürger; Frederick Naftolin; Ulrich Dirnagl; Robert Nitsch; Josef Priller Journal: FASEB J Date: 2005-01-25 Impact factor: 5.191
Authors: Alicia A Babcock; Martin Wirenfeldt; Thomas Holm; Helle H Nielsen; Lasse Dissing-Olesen; Henrik Toft-Hansen; Jason M Millward; Regine Landmann; Serge Rivest; Bente Finsen; Trevor Owens Journal: J Neurosci Date: 2006-12-06 Impact factor: 6.167
Authors: Mariko L Bennett; F Chris Bennett; Shane A Liddelow; Bahareh Ajami; Jennifer L Zamanian; Nathaniel B Fernhoff; Sara B Mulinyawe; Christopher J Bohlen; Aykezar Adil; Andrew Tucker; Irving L Weissman; Edward F Chang; Gordon Li; Gerald A Grant; Melanie G Hayden Gephart; Ben A Barres Journal: Proc Natl Acad Sci U S A Date: 2016-02-16 Impact factor: 11.205
Authors: Verónica Salas-Venegas; Rosa Pamela Flores-Torres; Yesica María Rodríguez-Cortés; Diego Rodríguez-Retana; Ricardo Jair Ramírez-Carreto; Luis Edgar Concepción-Carrillo; Laura Josefina Pérez-Flores; Adriana Alarcón-Aguilar; Norma Edith López-Díazguerrero; Beatriz Gómez-González; Anahí Chavarría; Mina Konigsberg Journal: Front Integr Neurosci Date: 2022-03-29
Authors: Phillip K West; Andrew N McCorkindale; Boris Guennewig; Thomas M Ashhurst; Barney Viengkhou; Emina Hayashida; So Ri Jung; Oleg Butovsky; Iain L Campbell; Markus J Hofer Journal: J Neuroinflammation Date: 2022-04-16 Impact factor: 9.587
Authors: Brandon Lucke-Wold; William Dodd; Kartik Motwani; Koji Hosaka; Dimitri Laurent; Melanie Martinez; Victoria Dugan; Nohra Chalouhi; Noelle Lucke-Wold; Arnav Barpujari; Christina von Roemeling; Chenglong Li; Richard D Johnson; Brian Hoh Journal: J Neuroinflammation Date: 2022-09-16 Impact factor: 9.587